At the Hannover Messe 2025 event, Siobhan Fleming, Digitalization Consultant for Pharma and Life Sciences, discusses how Siemens is pioneering AI solutions that empower pharmaceutical companies to enhance production processes, reduce time-to-market and ensure higher precision in drug manufacturing.
Siemens' AI-powered solutions are transforming the pharmaceutical industry at every stage—research and development (R&D), engineering and operations. Current drug development faces long timelines, but our advanced AI technology speeds up processes and supports pharma professionals by analyzing data quickly and reducing the need for physical experiments via digital solutions like simulation, digital twins and AI-powered experiment management.
GSK, a global biopharma company, leveraged Siemens' AI-powered technology to significantly enhance their vaccine development program. By integrating data from multiple physical and simulated sources and applying machine learning and AI, researchers could now predict key properties with incredible accuracy. This resulted in a 25% reduction in physical experiments. This implementation not only expedited their development timeline but also maintained high standards of quality and safety, showcasing the transformative impact of AI solutions on R&D processes in pharmaceuticals.